Donor Stem Cell Transplant in Treating Patients With High Risk Acute Myeloid Leukemia

Summary

This phase I trial studies the side effects of donor stem cell transplant in treating patients with high risk acute myeloid leukemia. Giving low doses of chemotherapy before a donor peripheral blood stem cell transplant helps stop the growth of cancer cells. It may also stop the patient's immune system from rejecting the donor's stem cells when they do not exactly match the patient's blood. The donated stem cells may replace the patient's immune cells and help destroy any remaining cancer cells (graft-versus-tumor effect)

Timeline

Start

2013-03-06

Primary completion

2017-07-27

Completion

2017-08-20

Drugs

Indications